Cargando…
CAR-NK as a Rapidly Developed and Efficient Immunotherapeutic Strategy against Cancer
SIMPLE SUMMARY: New approaches in adoptive immunotherapy using chimeric antigen receptor (CAR)-modified cells have been developing very quickly in recent years, entering into clinical trials and being accepted by health agencies worldwide. Although the classical CAR therapies using genetically engin...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817948/ https://www.ncbi.nlm.nih.gov/pubmed/36612114 http://dx.doi.org/10.3390/cancers15010117 |